Extracorporeal membrane oxygenation treatment. One-year outcomes for North Carolina infants

K U Boggs1, V E Visser

  • 1University of North Carolina, Charlotte.

Insights

Extracorporeal membrane oxygenation (ECMO) shows promising survival rates for neonates with pulmonary failure, with developmental outcomes comparable to national data. Congenital diaphragmatic hernia is a key factor influencing poorer results.

Area of Science:

  • Neonatal Medicine
  • Pediatric Critical Care
  • Cardiopulmonary Support

Background:

  • Extracorporeal membrane oxygenation (ECMO) is increasingly used for neonates with pulmonary failure.
  • Initial survival rates in North Carolina's ECMO program exceeded national averages.
  • Developmental outcomes at one year were comparable to existing literature.

Purpose of the Study:

  • To evaluate the outcomes of neonatal ECMO treatment in North Carolina.
  • To assess developmental functioning and family impact post-ECMO.
  • To identify factors associated with treatment success or failure.

Main Methods:

  • Retrospective analysis of the first 45 neonates treated with ECMO in North Carolina.
  • Assessment of developmental functioning at one year of age.
  • Evaluation of family functioning and perceived staff support.

Main Results:

  • Survival rates were favorable compared to national benchmarks.
  • Congenital diaphragmatic hernia was linked to significantly worse outcomes.
  • Family functioning measures were similar to non-ECMO intensive care populations.
  • ECMO staff support was highly rated by families.

Conclusions:

  • ECMO has transitioned to an established treatment for neonatal pulmonary failure.
  • Further research is needed on long-term effects and high-risk developmental follow-up.
  • Refinement of ECMO techniques and patient selection criteria is ongoing.